279 related articles for article (PubMed ID: 32924654)
1. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
[TBL] [Abstract][Full Text] [Related]
3. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
4. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
Gu JH; Zhao QY; He C; Ye ZD; Xu M; Jiang TA
Int J Hyperthermia; 2021; 38(1):1092-1098. PubMed ID: 34296656
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation.
Ishii T; Numata K; Hao Y; Doba N; Hara K; Kondo M; Tanaka K; Maeda S
Eur J Radiol; 2017 Apr; 89():234-241. PubMed ID: 28034569
[TBL] [Abstract][Full Text] [Related]
6. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation.
Zhou G; Cai ZQ; Luo J; Hu ZX; Luo H; Wu H; Chen Q
Asia Pac J Clin Oncol; 2019 Aug; 15(4):238-243. PubMed ID: 31119840
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
[TBL] [Abstract][Full Text] [Related]
11. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
12. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.
Liu LF; Ding ZL; Zhong JH; Li HX; Liu JJ; Li H; Li LQ
Biomed Res Int; 2018; 2018():8910562. PubMed ID: 30533441
[TBL] [Abstract][Full Text] [Related]
14. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography.
Kim AY; Lee MW; Rhim H; Cha DI; Choi D; Kim YS; Lim HK; Cho SW
Korean J Radiol; 2013; 14(5):754-63. PubMed ID: 24043968
[TBL] [Abstract][Full Text] [Related]
19. Computer-Aided Color Parameter Imaging of Contrast-Enhanced Ultrasound Evaluates Hepatocellular Carcinoma Hemodynamic Features and Predicts Radiofrequency Ablation Outcome.
Wang H; Guo W; Yang W; Liu G; Cao K; Sun Y; Liang ZN; Bai XM; Wang S; Wu W; Yan K; Goldberg SN
Ultrasound Med Biol; 2022 Aug; 48(8):1555-1566. PubMed ID: 35597704
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation.
Ma QP; He XL; Li K; Wang JF; Zeng QJ; Xu EJ; He XQ; Li SY; Kun W; Zheng RQ; Tian J
Mol Imaging Biol; 2021 Aug; 23(4):572-585. PubMed ID: 33483803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
